A federal court ruled against Pfizer last week in two of the three cases it filed against journals requesting confidential peer-review documents. The company lost against JAMA and the Archives of Internal Medicine, and is still waiting to hear on the decision for NEJM.
Get the full story
This story is free
for registered users
Registering provides access to this and other free content.
Register now.Already have an account?
Login Now.